VTMB / Vitamin Blue, Inc. - Depositi SEC, Relazione annuale, dichiarazione di delega

Vitamin Blue, Inc.
US ˙ OTCPK

Statistiche di base
CIK 1483623
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Vitamin Blue, Inc.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
January 31, 2014 15-12G

- FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-54257 Vitamin Blue, Inc. (Exact name of registrant as specified in its c

November 12, 2013 10-Q

Quarterly Report - VITAMIN BLUE, INC. 10Q 2013-09-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended September 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-54247 VITAMIN BLUE,

August 14, 2013 10-Q

Vitamin Blue VITAMIN BLUE, INC. 10Q 2013-06-30 (Quarterly Report)

vitaminblue.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended June 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-54247 VIT

May 20, 2013 10-Q

Vitamin Blue VITAMIN BLUE, INC. 10Q 2013-03-31 (Quarterly Report)

vitamin.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended March 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-54247 VITAMI

May 14, 2013 NT 10-Q

- VITAMIN BLUE, INC. FORM 12B-25

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.

April 23, 2013 8-K

Financial Statements and Exhibits - VITAMIN BLUE, INC. FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 17, 2013 Vitamin Blue, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54247 33-0858127 (State or other jurisdiction (Commission (IRS Employer of incorp

April 23, 2013 EX-10.2

April 17, 2013 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.2 April 17, 2013 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Notes (All Terms and Conditions) dated January 12, 2011 and March 1, 2011. Attachment A is attached. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to Casprey Capital Corp., a New

April 23, 2013 EX-10.1

April 17, 2013 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.1 April 17, 2013 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Notes (All Terms and Conditions) dated from September 24, 2010 through February 5, 2013. Attachment A is attached. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an

April 15, 2013 10-K

Vitamin Blue VITAMIN BLUE, INC. 10K 2012-12-31 (Annual Report)

vitaminblue.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ X ] Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2012 [ ] Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-5

April 1, 2013 NT 10-K

- VITAMIN BLUE, INC. FORM 12B-25

NT 10-K 1 vitaminbluent.htm VITAMIN BLUE, INC. FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 000-54247 NOTIFICATION OF LATE FILING CUSIP NUMBER 92849G 106 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10

September 17, 2012 8-K

- VITAMIN BLUE, INC. 8K 2012-09-11

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 11, 2012 Vitamin Blue, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54247 33-0858127 (State or other jurisdiction of incorporation) (Commission F

September 11, 2012 8-A12G

- VITAMIN BLUE 8-A12G 2012-09-11

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Vitamin Blue, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0858127 (State or incorporation or organization) (I.R.S. Employer Identification Number) 1005 West 18th Street,

July 31, 2012 S-1/A

- FORM S-1/A AMENDMENT NO. 5

As filed with the Securities and Exchange Commission on July 31 ,2012 Registration No.

July 18, 2012 S-1/A

- FORM S-1/A AMENDMENT NO. 3

As filed with the Securities and Exchange Commission on July 18 , 2012 Registration No.

June 22, 2012 EX-10.7

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.7 October 21, 2011 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Note dated March 17, 2011. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an individual, (the “Holder”) the principal sum as calculated and accrued pursuant to th

June 22, 2012 S-1/A

- FORM S-1/A AMENDMENT NO. 3

As filed with the Securities and Exchange Commission on June 22, 2012 Registration No.

June 22, 2012 EX-10.8

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.8 October 21, 2011 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Note dated March 17, 2011. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an individual, (the “Holder”) the principal sum as calculated and accrued pursuant to th

May 8, 2012 EX-10.2

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.2 October 21, 2011 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Note dated March 17, 2011. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an individual, (the “Holder”) the principal sum as calculated and accrued pursuant to th

May 8, 2012 EX-10.6

LOCK-UP AGREEMENT

Exhibit 10.6 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (the "Agreement") dated October 21, 2011 (the Effective Date”) by and between James M. Yeung (the "Shareholder") and Vitamin Blue, Inc., a Delaware corporation (the "Company"). WHEREAS, the Company has been assisting a market maker with its application on Form 211 before the Financial Industry Regulatory Authority (“FINRA”) to make a market in

May 8, 2012 EX-10.3

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.3 October 21, 2011 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Note dated March 17, 2011. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an individual, (the “Holder”) the principal sum as calculated and accrued pursuant to th

May 8, 2012 EX-10.1

AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE

Exhibit 10.1 October 21, 2011 AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE This Amended and Restated Convertible Promissory Note replaces and extinguishes the previously executed Convertible Promissory Note dated March 17, 2011. THEREFORE, FOR VALUE RECEIVED the undersigned, promises to pay to James Yeung, an individual, (the “Holder”) the principal sum as calculated and accrued pursuant to th

May 8, 2012 S-1/A

- FORM S-1/A AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on May 8, 2011 Registration No.

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista